SNDT WOMEN'S UNIVERSITY
BMK Knowledge Resource Centre
Vithaldas Vidyavihar, Juhu Tara Road,
Santacruz (West) Mumbai - 400049
Clinical observation of the transition from short-term intensive insulin therapy to IDegLira combined with metformin in Chinese patients with type 2 diabetes mellitus
Description: P 195-200Subject(s): In: Current ScienceSummary: The safety and efficacy of transitioning from short-term intensive insulin therapy to a regimen of insulin degludec/liraglutide (IDegLira) combined with metformin in type 2 diabetes mellitus patients is evaluated in the present study. Conducted at Shenzhen Luohu Hospital Group, the study involved 81 patients who switched from continuous subcutaneous insulin infusion to IDegLira and metformin after four days. Results showed significant improvements: insulin doses decreased from 40.28 to 14.79 IU, HbA1c levels fell from 9.94% to 7.67%, and body weight slightly reduced. The transition also enhanced glycemic control, with reduced mean glucose and variation, and increased time in range.| Item type | Current library | Call number | Vol info | Status | Barcode | |
|---|---|---|---|---|---|---|
| Journal Article | SNDT Juhu | Available | JP667.8 | |||
| Periodicals | SNDT Juhu | P 505/CS (Browse shelf(Opens below)) | Vol. 128, No. 2 (16/01/2025) | Available | JP667 |
The safety and efficacy of transitioning from short-term
intensive insulin therapy to a regimen of insulin degludec/liraglutide (IDegLira) combined with metformin in
type 2 diabetes mellitus patients is evaluated in the
present study. Conducted at Shenzhen Luohu Hospital
Group, the study involved 81 patients who switched
from continuous subcutaneous insulin infusion to
IDegLira and metformin after four days. Results showed
significant improvements: insulin doses decreased
from 40.28 to 14.79 IU, HbA1c levels fell from 9.94%
to 7.67%, and body weight slightly reduced. The transition also enhanced glycemic control, with reduced
mean glucose and variation, and increased time in
range.
There are no comments on this title.
Log in to your account to post a comment.